Financial News
Articles published by ICON plc
![](https://mms.businesswire.com/media/20240710959169/en/2181951/5/ICON_logo_high_res.jpg)
ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer
July 10, 2024
From ICON plc
Via Business Wire
Tickers
ICLR
![](https://mms.businesswire.com/media/20240701863048/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
![](https://mms.businesswire.com/media/20240604396876/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
![](https://mms.businesswire.com/media/20240530014410/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
![](https://mms.businesswire.com/media/20240520485580/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
![](https://mms.businesswire.com/media/20240509274727/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
![](https://mms.businesswire.com/media/20240430675153/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
ICON Announces Pricing of USD 2 Billion Notes
April 30, 2024
From ICON plc
Via Business Wire
Tickers
ICLR
![](https://mms.businesswire.com/media/20240424083968/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
![](https://mms.businesswire.com/media/20240403248673/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
![](https://mms.businesswire.com/media/20240325680956/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
![](https://mms.businesswire.com/media/20240226994125/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
ICON plc to Present at Upcoming Investor Conferences
February 26, 2024
From ICON plc
Via Business Wire
Tickers
ICLR
![](https://mms.businesswire.com/media/20240221492475/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
ICON Reports Fourth Quarter and Full Year 2023 Results
February 21, 2024
From ICON plc
Via Business Wire
Tickers
ICLR
![](https://mms.businesswire.com/media/20240130751222/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
![](https://mms.businesswire.com/media/20240124995130/en/2007946/5/ICON_logo_high_res.jpg)
New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment
January 24, 2024
From ICON plc
Via Business Wire
Tickers
ICLR
![](https://mms.businesswire.com/media/20240109333358/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
ICON Issues Financial Guidance for Full Year 2024
January 09, 2024
From ICON plc
Via Business Wire
Tickers
ICLR
![](https://mms.businesswire.com/media/20240108742855/en/1991802/5/ICON_logo_high_res.jpg)
Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON
January 08, 2024
From ICON plc
Via Business Wire
Tickers
ICLR
![](https://mms.businesswire.com/media/20240104297734/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
![](https://mms.businesswire.com/media/20231218732293/en/1973261/5/ICON_logo_high_res.jpg)
ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023
December 18, 2023
From ICON plc
Via Business Wire
Tickers
ICLR
![](https://mms.businesswire.com/media/20231207194275/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
ICON Secures Upgraded Credit Rating from Moody’s Investors Service
December 07, 2023
From ICON plc
Via Business Wire
Tickers
ICLR
![](https://mms.businesswire.com/media/20231107047223/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
ICON plc to Present at Upcoming Investor Conferences
November 08, 2023
From ICON plc
Via Business Wire
Tickers
ICLR
![](https://mms.businesswire.com/media/20231025382191/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
ICON Reports Third Quarter 2023 Results
October 25, 2023
From ICON plc
Via Business Wire
Tickers
ICLR
![](https://mms.businesswire.com/media/20231012433612/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
ICON Secures Upgraded Credit Rating from S&P Global Ratings
October 12, 2023
From ICON plc
Via Business Wire
Tickers
ICLR
![](https://mms.businesswire.com/media/20230921148039/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
ICON plc Schedules Third Quarter 2023 Earnings Conference Call
September 21, 2023
From ICON plc
Via Business Wire
Tickers
ICLR
![](https://mms.businesswire.com/media/20230920888786/en/1895055/5/ICON_logo_high_res.jpg)
ICON Releases Expanded End-to-end Clinical Trial Tokenisation Solution
September 20, 2023
From ICON plc
Via Business Wire
Tickers
ICLR
![](https://mms.businesswire.com/media/20230913208048/en/1889056/5/ICON_logo_alg_green.jpg)
BARDA Partners With ICON to Execute Next Generation COVID-19 Vaccines Clinical Trial
September 13, 2023
From ICON plc
Via Business Wire
Tickers
ICLR
![](https://mms.businesswire.com/media/20230906124201/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
ICON plc to Present at the Baird Global Healthcare Conference
September 06, 2023
From ICON plc
Via Business Wire
Tickers
ICLR
![](https://mms.businesswire.com/media/20230726555975/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
![](https://mms.businesswire.com/media/20230726452737/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
![](https://mms.businesswire.com/media/20230713464155/en/1840725/5/ICON_logo_high_res.jpg)
![](https://mms.businesswire.com/media/20230627427131/en/602293/22/ICON_Positive_logo_PNG_%28nostrap%29.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.